Min‐Wu Chao

719 total citations
26 papers, 492 citations indexed

About

Min‐Wu Chao is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Min‐Wu Chao has authored 26 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Min‐Wu Chao's work include Histone Deacetylase Inhibitors Research (7 papers), Cancer Mechanisms and Therapy (6 papers) and Computational Drug Discovery Methods (3 papers). Min‐Wu Chao is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Cancer Mechanisms and Therapy (6 papers) and Computational Drug Discovery Methods (3 papers). Min‐Wu Chao collaborates with scholars based in Taiwan, United States and China. Min‐Wu Chao's co-authors include Shiow‐Lin Pan, Jing‐Ping Liou, Che‐Ming Teng, Huang‐Ju Tu, Kai‐Cheng Hsu, Wei‐Chun HuangFu, Tony Eight Lin, Mei‐Jung Lai, Ya‐Ling Chang and Han-Li Huang and has published in prestigious journals such as Scientific Reports, Carcinogenesis and Protein Science.

In The Last Decade

Min‐Wu Chao

26 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Min‐Wu Chao Taiwan	15	364	149	86	46	39	26	492
Henrik Moebitz Switzerland	5	325 0.9×	119 0.8×	105 1.2×	58 1.3×	28 0.7×	8	441
Diana C. West United States	9	292 0.8×	146 1.0×	98 1.1×	39 0.8×	59 1.5×	10	525
Ahmed S.A. Mady United States	9	341 0.9×	114 0.8×	81 0.9×	32 0.7×	24 0.6×	13	444
Brian Zifcak United States	7	431 1.2×	136 0.9×	125 1.5×	51 1.1×	24 0.6×	10	570
Elin Lindhagen Sweden	14	245 0.7×	138 0.9×	50 0.6×	24 0.5×	67 1.7×	28	505
Xavier Billot Canada	7	463 1.3×	152 1.0×	144 1.7×	32 0.7×	55 1.4×	10	769
Yuzhu Zheng China	10	275 0.8×	129 0.9×	39 0.5×	20 0.4×	59 1.5×	15	450
Shan‐Liang Sun China	13	311 0.9×	117 0.8×	33 0.4×	30 0.7×	69 1.8×	37	465
Mingsong Shi China	14	261 0.7×	114 0.8×	131 1.5×	30 0.7×	32 0.8×	58	470
Claire McWhirter United Kingdom	5	394 1.1×	79 0.5×	48 0.6×	20 0.4×	44 1.1×	8	478

Countries citing papers authored by Min‐Wu Chao

Since Specialization

Citations

This map shows the geographic impact of Min‐Wu Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Wu Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Wu Chao more than expected).

Fields of papers citing papers by Min‐Wu Chao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Wu Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Wu Chao. The network helps show where Min‐Wu Chao may publish in the future.

Co-authorship network of co-authors of Min‐Wu Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Wu Chao. A scholar is included among the top collaborators of Min‐Wu Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Wu Chao. Min‐Wu Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chao, Min‐Wu, Hsueh‐Yun Lee, Yiting Liu, et al.. (2023). In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2166039–2166039. 5 indexed citations

Wu, Yiwen, Min‐Wu Chao, Huang‐Ju Tu, et al.. (2022). O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia. Phytomedicine. 100. 154061–154061. 7 indexed citations

Lin, Tony Eight, Chia‐Ron Yang, Min‐Wu Chao, et al.. (2021). Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment. Biomedicine & Pharmacotherapy. 146. 112459–112459. 15 indexed citations

Chao, Min‐Wu, Huang‐Ju Tu, Liang‐Chieh Chen, et al.. (2021). A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo. Oncogenesis. 10(5). 39–39. 24 indexed citations

Liu, Yi-Min, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2021). Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo. European Journal of Medicinal Chemistry. 219. 113428–113428. 14 indexed citations

Lin, Tony Eight, Min‐Wu Chao, Wei‐Chun HuangFu, et al.. (2021). Identification and analysis of a selective DYRK1A inhibitor. Biomedicine & Pharmacotherapy. 146. 112580–112580. 11 indexed citations

Ojha, Ritu, Kunal Nepali, Chun‐Han Chen, et al.. (2020). Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 190. 112086–112086. 35 indexed citations

Hsu, Kai‐Cheng, Wei‐Chun HuangFu, Tony Eight Lin, et al.. (2020). A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors. Scientific Reports. 10(1). 10510–10510. 8 indexed citations

Chao, Min‐Wu, Tony Eight Lin, Wei‐Chun HuangFu, et al.. (2020). Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 98–108. 14 indexed citations

10.

Mehndiratta, Samir, Mei-Hsiang Lin, Chun‐Han Chen, et al.. (2019). N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression. European Journal of Medicinal Chemistry. 185. 111725–111725. 49 indexed citations

11.

Chao, Min‐Wu, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2019). Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Clinical Epigenetics. 11(1). 85–85. 28 indexed citations

12.

Nepali, Kunal, Mei-Hsiang Lin, Min‐Wu Chao, et al.. (2019). Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells. Bioorganic Chemistry. 91. 103119–103119. 17 indexed citations

13.

Tu, Huang‐Ju, Min‐Wu Chao, Ting-Yi Sung, et al.. (2018). The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells. Clinical Epigenetics. 10(1). 162–162. 25 indexed citations

14.

Lin, Tony Eight, Wei‐Chun HuangFu, Min‐Wu Chao, et al.. (2018). A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions. Frontiers in Pharmacology. 9. 1379–1379. 31 indexed citations

15.

Chao, Min‐Wu, Han-Li Huang, Yu-Wei Chang, et al.. (2017). Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells. Scientific Reports. 7(1). 46134–46134. 35 indexed citations

16.

HuangFu, Wei‐Chun, Min‐Wu Chao, Jing‐Ping Liou, et al.. (2017). Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo. Scientific Reports. 7(1). 42291–42291. 4 indexed citations

17.

Hsu, En‐Chi, Samuel K. Kulp, Han-Li Huang, et al.. (2016). Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer. Carcinogenesis. 37(4). 430–442. 20 indexed citations

18.

Huang, Han-Li, Min‐Wu Chao, Chun‐Han Chen, et al.. (2016). MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis and potentiates antineoplastic effect of cisplatin in ovarian cancer. Scientific Reports. 6(1). 31664–31664. 15 indexed citations

19.

Huang, Han-Li, Min‐Wu Chao, Mei-Chuan Chen, et al.. (2016). LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo. Scientific Reports. 6(1). 27794–27794. 9 indexed citations

20.

Chao, Min‐Wu, Mei‐Jung Lai, Jing‐Ping Liou, et al.. (2015). The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo. Journal of Hematology & Oncology. 8(1). 82–82. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact